In the BioHarmony Drug Report Database

"Preview" Icon

Mefenamic acid

Ponstel (mefenamic acid) is a small molecule pharmaceutical. Mefenamic acid was first approved as Ponstel on 1982-01-01. It is used to treat dysmenorrhea, fever, menorrhagia, and premenstrual syndrome in the USA. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2. In addition, it is known to target transient receptor potential cation channel subfamily M member 3, potassium voltage-gated channel subfamily KQT member 1, and aldo-keto reductase family 1 member C3.


Trade Name



Common Name


mefenamic acid






dysmenorrhea, fever, menorrhagia, premenstrual syndrome

Drug Class


Anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters

Image (chem structure or protein)

Mefenamic acid structure rendering